Literature DB >> 7115837

Hyperprolactinemia and sexual disorders in men.

M F Schwartz, J E Bauman, W H Masters.   

Abstract

One hundred and thirty-six men, who presented at Masters & Johnson Institute for treatment of impotence, ejaculatory incompetence, and inhibited sexual desire, underwent endocrine screening. Eleven men (8.1%) were found to be hyperprolactinemic: three had a mild degree of hyperprolactinemia while eight had markedly elevated serum prolactin levels in conjunction with subnormal serum testosterone levels. The markedly hyperprolactinemic men, all of whom were subsequently found to have prolactin-secreting pituitary adenomas, presented with diverse histories of sexual disorders which were similar to those of men with psychogenic sexual dysfunctions. All eight experienced some degree of improvement of sexual function following a 2-week course of intensive psychotherapy, although full restoration of libido was contingent on reduction of circulating prolactin to normal or near-normal levels. Measurement of prolactin levels should be routinely performed in all men presenting with the above sexual disorders and depressed testosterone levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115837

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

1.  Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.

Authors:  J J Miceli; K D Wilner; R A Hansen; A C Johnson; G Apseloff; N Gerber
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

2.  Plasma prolactin and estradiol during sleep in impotent men and normal controls.

Authors:  R C Schiavi; C Fisher; D White; J Thornton
Journal:  Arch Sex Behav       Date:  1986-08

3.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10

4.  Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone.

Authors:  Hong Liu-Seifert; Bruce J Kinon; Christopher J Tennant; Jennifer Sniadecki; Jan Volavka
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.